Keros Therapeutics (KROS) has issued an announcement.
Keros Therapeutics, Inc. has refreshed its corporate presentation, which is now accessible on their website for investors, analysts, and other interested parties. This update, disclosed in a recent report, is not intended for official filing purposes but is provided for informational reasons, highlighting the company’s ongoing dedication to transparency and engagement with the financial community.
For detailed information about KROS stock, go to TipRanks’ Stock Analysis page.
